Clinical Study
Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
| | Number | Age | Gender | Etiology | BCLC | C-P score | Splenic volume (mL) | Extent of necrosis (%) | Platelet count (/mm3) | Hospital time (days) | Introduction of SC | | Before | After 1 month |
| | 1 | 48 | M | HCV | B | 5 | 578.4 | 45.3 | 4.8 | 11.7 | 11 | Success | | 2 | 60 | M | HCV | B | 5 | 990.5 | 38.9 | 3.9 | 6.0 | 10 | Success | | 3a | 64 | M | NBNC | B | 7 | 1116.6 | 39.1 | 3.9 | 5.6 | 11 | Failure | | 4 | 57 | M | HCV | B | 5 | 528.3 | 40.6 | 2.7 | 4.3 | 13 | Failure | | 5b | 65 | M | HCV | B | 7 | 426.3 | 36.3 | 2.4 | ND | 12 | Failure | | 6 | 48 | M | HBV | C | 6 | 948.1 | 68.5 | 4.8 | 17.5 | 20 | Success | | 7 | 63 | M | HCV | B | 6 | 656.7 | 72.5 | 4.6 | 15.1 | 15 | Success | | 8 | 78 | F | HCV | C | 5 | 727.0 | 42.7 | 3.7 | 6.0 | 9 | Success | | 9 | 55 | M | HCV | B | 5 | 401.3 | 19.5 | 4.9 | 7.2 | 12 | Success | | 10 | 82 | M | NBNC | B | 8 | 472.4 | 40.2 | 4.8 | 8.7 | 9 | NA | | 11 | 55 | M | HBV | B | 7 | 896.8 | 21.0 | 4.1 | 6.1 | 8 | NA | | 12c | 66 | M | HCV | B | 7 | 815.9 | 30.2 | 4.5 | 4.6 | 12 | NA | | 13 | 54 | M | NBNC | B | 5 | 469.5 | 23.5 | 4.6 | 13.1 | 11 | Success | | 14 | 64 | M | HBV | B | 5 | 469.5 | 20.1 | 4.8 | 13.7 | 9 | Success | | 15 | 64 | M | HCV | B | 5 | 997.7 | 31.1 | 3.9 | 9.4 | 10 | Success | | 16 | 61 | M | HCV | B | 6 | 411.9 | 47.7 | 4.6 | 7.3 | 9 | NA | | 17 | 76 | M | HCV | B | 6 | 287.7 | 51.2 | 4.4 | 7.9 | 12 | Success | | 18 | 53 | M | HCV | C | 6 | 270.3 | 81.6 | 4.9 | 15.4 | 8 | Success | | 19d | 65 | M | HCV | B | 8 | 785.5 | 77.0 | 3.4 | ND | 17 | Failure | | 20 | 68 | M | NBNC | C | 6 | 491.1 | 30.1 | 3.4 | 8.7 | 20 | Success | | 21 | 77 | M | HCV | B | 6 | 499.6 | 36.0 | 4.8 | 7.7 | 10 | Success |
| | Mean | | | | | | | | | | | |
|
|
Complicated by portal vein thrombosis, blost to follow-up, cno effect despite two additional PSE, dcomplicated by lethal liver failure; BCLC, Barcelona Clinical Liver Center; C-P, Child-Pugh; SC, systemic chemotherapy; HBV, hepatitis B virus; HCV, hepatitis C virus; NBNC, non-HBV and non-HCV; PSE, partial splenic embolization; ND, not determined; NA, not applicable.
|
